Gemvaxlink Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was KRW 16,890.19 million compared to KRW 23,365.15 million a year ago. Net loss was KRW 5,587.12 million compared to KRW 4,799.99 million a year ago. Basic loss per share from continuing operations was KRW 72 compared to KRW 57 a year ago. Diluted loss per share from continuing operations was KRW 72 compared to KRW 57 a year ago. Basic loss per share was KRW 72 compared to KRW 57 a year ago.
For the nine months, sales was KRW 50,897.35 million compared to KRW 75,481.34 million a year ago. Net loss was KRW 6,749.64 million compared to KRW 10,813.05 million a year ago. Basic loss per share from continuing operations was KRW 85 compared to KRW 130 a year ago. Diluted loss per share from continuing operations was KRW 85 compared to KRW 130 a year ago. Basic loss per share was KRW 85 compared to KRW 130 a year ago.